Medicare Enrolled

Dr. Afshin Ashrafian, MD

Family Medicine · North Richland Hills, TX
Low-engagement
7601 GLENVIEW DR, North Richland Hills, TX 76180
8172742578
In practice since 2007 (18 years)
NPI: 1750508032 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ashrafian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ashrafian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ashrafian

Dr. Afshin Ashrafian is a family medicine in North Richland Hills, TX, with 18 years in practice.

Between the years covered by Open Payments, Dr. Ashrafian received a total of $7,493 from 51 pharmaceutical and/or device companies across 481 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ashrafian is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $7,493 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,493
Total received (2018-2024)
Avg $1,070/year across 7 years
Top 8% in TX for family medicine
51
Companies
481
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,493 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,333
2023
$1,481
2022
$935
2021
$1,122
2020
$866
2019
$683
2018
$1,074

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$878
Lilly USA, LLC
$717
GlaxoSmithKline, LLC.
$667
Novo Nordisk Inc
$510
ABBVIE INC.
$438
Janssen Pharmaceuticals, Inc
$402
Merck Sharp & Dohme Corporation
$353
Boehringer Ingelheim Pharmaceuticals, Inc.
$323
AbbVie Inc.
$319
Takeda Pharmaceuticals U.S.A., Inc.
$303
Amarin Pharma Inc.
$267
Abbott Laboratories
$202
IDORSIA PHARMACEUTICALS US INC
$187
Amgen Inc.
$168
PFIZER INC.
$146
Astellas Pharma US Inc
$133
Exact Sciences Corporation
$124
Otsuka America Pharmaceutical, Inc.
$120
Dexcom, Inc.
$101
SANOFI-AVENTIS U.S. LLC
$96
SCILEX PHARMACEUTICALS INC.
$82
Biohaven Pharmaceuticals, Inc.
$77
Novartis Pharmaceuticals Corporation
$55
Eisai Inc.
$53
Allergan, Inc.
$50
Corium, LLC
$50
Medtronic, Inc.
$46
Kowa Pharmaceuticals America, Inc.
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$40
SANOFI PASTEUR INC.
$38
Intuitive Surgical, Inc.
$37
Supernus Pharmaceuticals, Inc.
$36
Axsome Therapeutics, Inc.
$35
Dynavax Technologies Corporation
$35
Genentech USA, Inc.
$32
Esperion Therapeutics, Inc.
$30
Ironwood Pharmaceuticals, Inc
$27
MannKind Corporation
$26
Biohaven Pharmaceutical Holding Company Ltd.
$24
Allergan Inc.
$23
Scilex Pharmaceuticals Inc.
$23
AbbVie, Inc.
$23
Horizon Pharma plc
$21
Lundbeck LLC
$19
Teva Pharmaceuticals USA, Inc.
$18
Paratek Pharmaceuticals, Inc.
$18
Cranial Technologies, Inc
$17
Seqirus USA Inc
$16
Phadia US Inc.
$15
Arbor Pharmaceuticals, Inc.
$15
Ultragenyx Pharmaceutical Inc.
$15
Top 3 companies account for 30.2% of total payments
Associated products mentioned in payments ›
ABRYSVO · AFREZZA · ANORO · AREXVY · Aimovig · Allure Quadra RF CRT Pacemaker · Auvelity · Azstarys · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Crysvita · Da Vinci Surgical System · Dayvigo · Dexcom G6 Transmitter · Doc Band · EMGALITY · ENTRESTO · Edarbi · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · Heplisav-B · INTELLIS ADAPTIVESTIM · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · LINZESS · Livalo · MOUNJARO · NEXLETOL · NURTEC ODT · NUZYRA · Otezla · Ozempic · PREVNAR 20 · QELBREE · QULIPTA · QUVIVIQ · RAYOS · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYMBICORT · Synthroid · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Trintellix · UBRELVY · VESICARE · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · Xofluza · ZORYVE · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for family medicine in TX.

Looking for a family medicine in North Richland Hills?
Compare family medicines in the North Richland Hills area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
1,393
Per 100K population
65.2
County median income
$81,905
Nearest hospital
MEDICAL CITY NORTH HILLS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ashrafian is a family medicine, and high industry engagement (low-engagement, top 8%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ashrafian receive payments from pharmaceutical companies?
Yes. Dr. Ashrafian received a total of $7,493 from 51 companies across 481 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Ashrafian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →